This week in gene and cell therapy - 9 March 2018
Gene and cell therapy headlines 5 - 9 March
New xCas9 variant has higher specficity and broader PAM compatibility
Oxford based Nightstart to launch phase III clinical trial of gene therapy for choroideremia
MeirGTx recevies EMA PRIME designation for treatment of achromatopsia
AbbVie and Voyager Therapeutics to collaborate on gene therapy for Alzheimer's disease
FDA sets out path for stem cell therapies